deafness
Sensorion to Raise €15M Through Reserved Offering of Shares
The funds will allow the firm to advance two gene therapies it is developing for monogenic forms of hearing loss.
The funds will allow the firm to advance two gene therapies it is developing for monogenic forms of hearing loss.